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Differential Expression of Chemokines 
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Susan H. Jackman, I Matthew B. Yoak, 2 Shivaleela Keerthy, I Bonnie L. Beaver2 
Marshall University School of Medicine, Huntington, West Virginia 
1 Department of Microbiology, Immunology, & Molecular Genetics; 2 Department of Surgery 
Abstract. Macrophages have a multifaceted role in wound healing. While their initial activity may be in the 
degradation and elimination of damaged tissue, macrophages also produce and secrete a variety of mediators 
that can participate in the repair process as well. To perform these functions, macrophages must be recruited to 
a wound site. Our purpose was to examine the temporal and spatial expression of macrophage chemoattracting 
cytokines (chemokines) at a surgical wound site. A surgical wound was prepared on the dorsal aspect ofB6AFI/J 
mice .. Biopsies were obtained from the wound and a comparable nonwounded area between 6 and 72 hr after 
wounding. The presence or absence of various chemokine mRNAs was detected by the reverse transcriptase-
polymerase chain reaction (RT-PCR). Immunohistochemical staining and in situ RT-PCR determined localization 
of cells producing chemokines. In wounded tissue, both macrophage chemoattractant protein- I (M CP -1) and 
macrophage inflammatory protein-1 (MIP -1) were detected; however, the time of expression differed for each 
molecule. MCP-1 mRNA was detected at 6 hr after wounding, with decreased expression at subsequent time 
periods. In contrast, MIP-1 messages were not observed until 24 hr after wounding, and steadily increased 
thereafter. MCP-1 and MIP-1 mRNA and protein were localized predominantly in keratinocytes. The rapid 
and strong expression of MCP-1 and MIP -1 messages within the wound site suggests a pivotal role for these 
chemokines in the repair process. The differences in appearance and level of expression over time, however, 
suggest distinctive functions for each chemokine and indicate that the local milieu, rather than a single cytokine, 
influences macrophage recruitment and/or activation. 
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Introduction 
Healing of wounds requires a network of repair 
mechanisms that influence the recruitment and 
infiltration of leukocytes at the wound site. During 
the inflammatory phase of the repair process, 
macrophages are found in increasing numbers and 
have been shown to be necessary for wound repair 
[1,2]. Yet certain growth factors and cytokines that 
are produced and secreted by activated macrophages 
have also been implicated in the scarring that occurs 
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during wound healing [3]. Understanding the early 
mechanisms by which macro phages are recruited to a 
wound site could assist in managing the potential 
adverse effects of macrophage activation, without 
inhibiting the positive functions that macrophages 
perform in wound repair. 
The ability to attract monocytes from blood into 
tissue, where monocytes then differentiate into 
activated macro phages, is proposed to be one function 
of the chemoattracting cytokines, called chemokines. 
The various chemokines appear to be both pleotrophic 
and redundant with respect to their target cells and 
biological activities, at least when studied in vitro [4]. 
Local expression of cytokines is required for the 
migration of monocytes to extravascular sites [5-7]. 
While macrophage chemoattractant protein-1 {M CP-1) 
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[5,6] and macrophage inflammatory protein-1 (MIP-1) 
[6-9] have both been observed within wounds, 
correlation of their appearance has not been explored. 
To investigate the roles of these monocyte-attracting 
chemokines in wound healing, we have used a murine 
model of wounding to establish their temporal and 
site-specific expression early in the repair process. 
Methods and Materials 
Animals. Female B6AF1/J mice were purchased from 
The Jackson Laboratory (Bar Harbor, ME), housed in 
a conventional animal facility, and given food and water 
ad libitum. Animals were used at 9-16 weeks of age. 
All experiments were approved by the Institutional 
Animal Care and Use Committee of Marshall 
University School of Medicine. 
Experimental design. Mice were anesthetized, the hair 
on the dorsal aspect was shaved, and the skin was 
prepared for surgery by swabbing with iodine solution. 
A single 25-30 mm full-thickness incision was made 
and the wound was closed with stainless steel staples. 
On some animals, a second site on the dorsal aspect 
was designated as nonwounded; here the hair was 
shaved and iodine was applied but no wound was made. 
This site was at least 8 mm from the wounded site. At 
6, 24, 48, and 72 hr after wounding, the wound and 
nonwounded sites were excised. Control untreated 
skin, that is, skin from animals not shaved nor swabbed 
with iodine solution, was also used. Each excised site 
was divided into three pieces. One piece was place in 
10% buffered formalin, embedded in paraffin, 
sectioned, and stained with hematoxylin and eosin. A 
second piece was cut into small segments and snap-
frozen in liquid nitrogen for RNA extraction. The 
third piece was frozen in liquid nitrogen for in situ 
RT-PCR and immunohistochemistry. . 
RNA extraction and RT-PCR. Tissues were 
homogenized with a Tekmar SDTTissumizer (Tekmar, 
Cincinnati, OH) and total cellular RNA was extracted 
using TRizol Reagent (Life Technologies, Grand Island, 
NY), according to the manufacturer's instructions. The 
extracted RNA was stored at -70°C. RNA in RNase-
free water was first incubated for 3 min at 70°C and 
chilled on ice. eDNA was synthesized from 1 J..Lg total 
RNA in a 30 J..Ll reaction volume using Moloney murine 
leukemia virus reverse transcriptase (Gibco-BRL, 
Gaithersburg, MD) and oligo d(T) l6· Four J.ll aliquots 
of the eDNA reaction products were amplified by PCR 
in 50 J.!l reactions using Taq polymerase (PE Applied 
Biosystems, Foster City, CA) and 0.4 J.!M each of the 
respective primers. The reaction consisted of23 (MCP-
1) or 35 (all other reactions) cycles in a Perkin-Elmer 
DNA Thermal Cycler Model480, with denaturation 
at 95°C for 1 min, annealing at 60°C for 1 min, and 
extension at 72°C for 2 min. After the final cycle, the 
temperature was maintained for an additional 7 min 
at 72°C. PCR products were analyzed by electro-
phoresis on 3% NuSieve/1% SeaKem agarose gels 
(FMC Bioproducts, Rockland, ME) and visualized by 
ethidium bromide staining. Starting quantities of 1-6 
x 10-10 J..Lg of chemokine/cytokine specific cDNAs 
produced detectable PCR products. Photographs of 
the gels were taken with Polaroid 667 film. The prints 
were scanned using Adobe Photoshop software and 
inverted images were printed onto Hewlett Packard 
transparency film (Palo Alto, CA). Band intensities 
were quantified by densitometry using a Personal 
Densitometer (Molecular Dynamics Inc, Sunnyvale, 
CA) with an OD260 limit of sensitivity of 0.01 units. 
After subtracting background OD26o• the relative level 
for each chemokine or cytokine was calculated as 
OD26o for the chemokine or cytokine band, divided 
by the OD26o for the ~-actin band. ~-actin (540 base 
pair product), MIP-1 (279 base pair product), and 
TGF-~ (525 base pair product) primers were purchased 
from Clontech (Palo Alto, CA). The MCP-1 and 
oligo d(Th6 primers were synthesized at the Marshall 
University DNA Core Facility. The MCP-1 primer 
sequences were as follows: 
5'primer 5'AGCACCAGCCAACTCTCACT3' and 
3'primer 5'TCTGGACCCATTCCTTCTTG3' (301 
base pair product). 
In situ (IS) RT-PCR. IS RT-PCR was performed using 
IS PCR glass slides and the GeneAmp in situ PCR 
system 1000 (PE Applied Biosystems). Ten-J..Lm frozen 
sections were placed on slides and fixed with 4% 
paraformaldehyde in Dulbecco's phosphate buffered 
saline (D PBS) for 15 min on ice. In some experiments, 
sections were permeabilized with 0.1 o/o saponin in 
DPBS for 5 min on ice. After washing, DNA was 
digested with 2U/~l DNase (Worthington 
Biochemicals, Freehold, NJ) solution containing 0.1 
M sodium acetate and 0.005 M MgSO for 4 hr at 
37°C and again in fresh DNase overniiht at 37°C. 
After washing, eDNA was synthesized at 42°C for 60 
min. On each slide, one section was incubated in a 
eDNA reaction mixture without reverse transcriptase 
and served as a negative control. PCR was performed 
using a 50 ~1 reaction mixture containing 1x IS PCR 
reaction buffer, 4.5 mM MgC1
2
, 0.2 mM each 
deoxynucleoside triphosphates, 50 ~1 IS Taq 
polymerase (PE Applied Biosystems), 10 ~M 
digoxigenin-11-dUTP (Boehringer Mannheim, 
Indianapolis, IN), and 0.8 ~M each of the respective 
primers (M CP -1 and MIP -1). Amplification consisted 
of 2 min at 95°C, then 30 cycles of denaturation at 
95°C for 1 min and annealing at 60°C for 1 min with 
a final extension at 72°C for 7 min. After washing, 
incorporation of digoxigenin-11-dUTP was 
demonstrated by incubation in alkaline phosphatase 
conjugated anti-digoxigenin (Boehringer Mannheim) 
overnight at 4 °C, followed by visualization using Vector 
Red substrate (Vector Laboratories, Burlingame, CA). 
Sections were counterstained with hematoxylin. Five 
samples representing three different time periods were 
analyzed for each chemokine. 
Immunohistochemistry. Skin tissue was snap-frozen 
in liquid nitrogen and stored at -70°C. Cryosections 
(1 0 !lm) were fixed in acetone for 5 min at room 
temperature and then stored at -20°C until used. All 
staining was performed at room temperature in a 
humidified chamber. On the day of staining, sections 
were incubated in 1 Oo/o normal goat or hamster serum, 
followed by avidin-biotin blocking solution (Vector, 
Burlingame, CA). After washing, they were reacted 
with primary antibody directed to MCP-1 (hamster 
anti-mouse MCP-1, Pharmingen, San Diego, CA) or 
MIP-1 (goat anti-mouse MIP-1a, Sigma, St. Louis, 
MO), then with biotin-conjugated anti-species IgG. 
An avidin: biotinylated horseradish peroxidase complex 
(Vectastain ABC Reagent, Vector) was used with 
3,3'-diaminobenzidine and hematoxylin counterstain 
to visualize cells. Tissue sections treated with PBS 
instead of the primary antibody served as control 
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samples and gave negative results. Two samples 
representing two different time periods were analyzed 
for each chemokine. 
Statistical analysis. Wounded and nonwounded skin 
were compared to control (normal) skin for chemokine 
and cytokine expression. Some groups were not 
normally distributed and non parametric methods were 
therefore used. Groups were compared using the 
Kruskal-Wallis one-way ANOVA test (SigmaStat 2.0 
program). Significance was defined asp < 0.05. 
Results 
Detection of chemokine mRNA. We recently 
demonstrated the expression of monocyte-attracting 
chemokine mRNAs during experimental mouse 
wound healing, using RT-PCR [1 0]. Because induction 
of chemokines appears exquisitely sensitive to variations 
in the tissue environment, we wished, in addition, to 
determine the expression of certain chemokines in 
normal control skin. In this study, we have confirmed 
our findings for the chemokines, MCP-1 and MIP-1, 
and the cytokine, TGF-B, and we have compared their 
expression in wounded and nonwounded skin with 
control (normal) skin, that is, skin neither wounded 
nor prepared for surgery. Table 1 shows data for gene 
expression of MCP-1, MIP-1 and TGF-B at specific 
time periods after wounding. Chemokine or cytokine 
values are standardized to B-actin for each specimen 
(eg, MCP-1/B-actin ratio) and the data are reported 
as relative levels. 
MCP-1 mRNA, while undetectable in control 
skin, was observed in some animals as early as 6 hr 
after wounding. By 24 hr, MCP-1 message was found 
in all animals and the levels were significantly higher 
in wounded versus control skin at this time and at 48 
hr after wounding (p <0.05). Whereas MCP-1 
expression was also observed in nonwounded skin, the 
levels were not significantly different from those found 
in control skin at any time point. 
In contrast, the expression of MIP-1 mRNA, 
which is constitutively expressed in control (normal) 
skin, was dramatically reduced at 6 hr and appeared to 
be the result of preparing the skin for surgery, in that 
nonwounded and wounded skin both showed this 
effect. At 24 hr, MIP -1 message was observed in 
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Table I. Relative levels of chemokines and cytokines in control, nonwounded, and wounded skin samplesa 
Skin sample MCP-1 MIP-1 TGF-~ 
& N mean±SD N mean±SD N mean±SD 
time [median] [median] (median] 
Control 3 o.ooh 3 0.37±0.16 3 1.61±0.10 
[0.00] (0.441 [1.56] 
Nonwounded 
6 hr 3 0.30±0.52 3 o.ooc 4 0.98±1.67 
[0.00] [0.00] [0.23} 
24 hr 5 0.08±0.05 5 o.ooc 5 0.61±0.14C 
[0.09] [0.00] [0.61] 
48 hr 4 0.08±0.12 4 o.ooc 4 0.76±0.47C 
[0.04] [0.00] [0.58] 
72 hr 4 0.08+0.14 4 0.40±0.43 4 0.81±0.32C 
(0.01] [0.37] [0.94] 
Wounded 
6 hr 5 0.59±0.56 5 o.ooc 5 0.72±0.35 
[0.82] [0.00] [0.53] 
24 hr 6 0.38±0.28C 6 O.l6±0.13C 6 0.64±0.32C 
(0.36] [0.14] [0.531 
48 hr 5 0.30±0.}9C 5 0.37±0.22 5 0.55±0.23C 
[0.21] [0.28] [0.57] 
72hr 6 0.49±0.50 6 0.67±0.31 6 0.88±0.39C 
[0.40] [0.68] [0.93] 
aN"' number of specimens analyzed. b Chemokine/cytokine levels below the detection limits are given a value of 0.00. 
c p <0.05 vs control skin samples, computed by Kruskal-Wallis one-way ANOVA .. 
wounded skin, albeit at low levels, and it recovered to 
control skin levels by 48 hr. In comparison, MIP-1 
was not detected in nonwounded skin until 72 hr, at 
which time it had returned to control skin levels. 
TGF-~ transcripts were also examined and 
comparable levels were found in both wounded and 
nonwounded skin, but were significantly decreased 
relative to control skin (p<0.05), with the exception 
of samples obtained at 6 hr after wounding. 
In situ localization of MCP-1 and MIP-1. In situ 
RT-PCR was used to study the distribution ofMCP-1 
and MIP-1 mRNA in wounded skin (Fig. lA, IB). 
Sections were first treated with DNase to remove 
genomic DNA and then reverse transcribed to generate 
eDNA for all mRNAs. This was followed by ampli-
fication with specific primers. For both MCP-1 and 
MIP-1, intensely positive single cells were found in a 
scattered pattern in the epidermis. Other cells positive 
for both chemokines were detected mainly in the lower 
dermis. MIP-1 mRNA was also consistently observed 
in follicular epithelium and sebaceous gland cells, while 
MCP-1 mRNA was only occasionally found in this 
location. Specificity of the messages was confirmed 
by lack of signal in sections incubated without reverse 
transcriptase (Fig. 1 C). 
The presence ofMCP-1 and MIP-1a protein in 
wounded skin was detected by immunohistochemical 
Hr,. I. J .ocali:-.uion of MCl'·l '"'d MIP-1 m.KNA by in situ RT-l'CR. Ti.<>ue sections from wnunded skin, treated with 
DNwe to ocmovc genomic D!\JA. -were rt:vc::uc rwuc1·Ched ~tlC.i c h~n amprilkd ''-'i• f1 S!lt:dtl,: l'timt:n and labclc<l m.1deotidc:. 
PCR produ<" were detectod ~'Y ;uttibody tn d,. nud•otidc label. At 72 lor anrr wounding, MCP-1 (;\) and ~lP-1 (lj) 
message:; we~ (c)und \\-ichin dte epi(ferm(s, hair fuHk1t:s, ;,md sdt::tccous gland~. and in ,:~U~ ln t'1e li'>Wt:"I <l~rtuls. {C} A 
n~tl,•econttol section. treated :AS dcs.ct·ibed hut nor reverse tr3JlSCti6ed pri<tr rn PCR.arnpliflc.aliou, d~rnonstmocs:. ncg~ti,,c 
!\:action; secdun :;hown is fcn .\4( ;p_ 1, with similar rcsufL,. for Mlfl-1. 1 hG pl:orograph d~picLS ri,..~uc: .lJ)J)I'l.t:<im.u.d}· I mm 
from che indskm sit~. (Vcccor Red ch1't)fllogr.n with hanatOX}'Iin: origiu:ll ntolgn.itk~rir.m xl50). 
-lt•ining. ~Cl'-1 immuttoteactivity '"·' found 
predominantly wit.hin the <piderntis (rig. 2.'\) corres-
ponding to MCP-1 mR~A expression. Likewise . 
.\111'-let protein p.r~lleled its m RK A \octli:L.1rion. wich 
positive sto.itting itt the epidermis attd follkular 
L1'itholium and in assuciatiou with ,,t:haccmL' gland.s 
(fig. 2B). We•lc hur spcdlic: Mll'-lo: re-activity wa.< 
~!so ob.etved it> dcrtual t:dls (Pit:- 2R). No .raining 
for either prutein could. bo <letoc:tc-d in control seCtions 
in which tlu: primary antib<>dyw•s not used (rit:· 2C). 
For both tech niquc~, rhe srai n5ng patccrn.~ were 
independently "'sessed by rwo ofche author:; •nd were 
cnnfirmed by a c·f\ird person with ~xpcnise in 
microanarom}: 
Fig. 2. Localizadon ofMCP -1 and ~·HP -1 a prutdn by .ln)muru)hiM ln::ht:nli~u-;. .. Ti:,sllc sc.:t.iuns l'mm sl<in G h1· afoc1· wounding 
io·· MCI'-1 (A) or 72 hr >ft·•· WOllllding r()r Mli'·lll (U) reveal spt-cific signal within the epidcnnis :md '" edb iro '"' drrorus. 
\1flJ.-ja is :tlso found in h~lrf(lllicl~ :~nd schact:nm ~bnd.s (B). (C) S~cLi.<)th h1 whi.dl Lhc:: ]Jrlnlacy 3U{ibodywas llOL uSt-d 
dcmoh:,t1·a1e ~l ncgatr:c rcac(ion; soc.tion ~hown fur 1\:ICI'-l with l:omp:trablr: ~ .. ~uln fl1r ~ .. iJI)-1tl. '11u: phntt'J~r.aph clc:piciS 
tismc approxjm.1tc::ty 1 tn11l fr<un tht: irH.:isl<nl siLc. (DAB duomogt:n with hcmaro.~:in; origin:1~ magnlficacion x 400). 
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Discussion 
Elucidating the mechanism for recruitment and 
activation of macrophages at a wound site is essential 
for a complete understanding of this cell's role in the 
repair process. In the present study, we employed a 
surgically wounded mouse model to examine the 
pattern and localization of monocyte-attracting 
chemokine gene expression in vivo. 
Prior studies in mice and humans show that M CP-
I [5-7] and MIP-I [6-9] are both associated with 
wounding. Whereas in previous investigations, each 
chemokine was studied either individually or at only 
one time period, in this study we tested both M CP -I 
and MIP-I at several times after wounding. MCP-I 
appeared before MIP-I, with expression at 6 hr after 
wounding [5], while MIP-I did not appear until 24 
hr, with increasing expression through 72 hr [8,9]. 
These present results confirmed previous findings. 
Our experimental design, however, revealed several 
unexpected observations in regard to MCP-I 
expression. First, by making a distinction between 
nonwounded versus control (normal) skin, we found 
MCP-I, albeit at very low levels, in nonwounded but 
not control skin. While this difference may reflect the 
biopsy of nonwounded skin too dose to the wound, 
careful efforts were made to delineate the two samples. 
Alternatively, our observation suggests that induction 
ofMCP-I gene expression at cutaneous sites is highly 
sensitive to mechanical or chemical stress and that the 
clipping of hair and/or treatment of the site with iodine 
in preparation for surgery may have initiated the slight 
expression of MCP-I detected in nonwounded skin. 
Indeed, induction of cytokine expression is reported 
in mild epidermal barrier disruption in humans [II], 
lending support to this hypothesis. In addition, the 
appearance ofMCP-1, even within wounded skin, was 
at relatively low levels, an observation that is consistent 
with reports that tissue-specific low levels result in 
accumulation of monocytes, while high levels of 
expression do not [I2]. This suggests that inducing 
the optimal amount of MCP-1, rather than eliciting 
expression per se, may be necessary for the recruitment 
of monocytes/macrophages to a wound. 
For MIP-I mRNA, we observed constitutive 
expression in normal skin, supporting most [I5-I7] 
but not all [9] investigations. Based on these levels in 
control skin, the striking lack of MIP-1 at 6 hr post 
wounding, with a gradual increase to normal skin levels, 
implies an alternative function for this chemokine. 
Rather than recruiting macrophages to a wound site, 
MIP-1 may instead fine-tune the macrophages' 
activities [ 19] and promote other wound repair 
processes [9]. The increase in MIP-1 message after 
the appearance ofMCP-I in our model suggested that 
MIP-1 was modulating the inflammatory response 
rather than initiating it. 
Cytokines are seldom expressed in isolation from 
other cytokines, so functionality must be assessed in 
conjunction with other molecules in the local milieu. 
TGF-I3, a pleotrophic molecule involved in promoting 
the repair process [ 13], has also been shown to have an 
inhibitory effect on MCP-1 expression in macrophages 
[I4]. Decrease in TGF-13 in our model, concomitant 
with increased MCP-1 expression, suggests that 
physiologic concentrations in concert with timed 
expression may determine the function of a cytokine 
at a local site. 
In our study, we also investigated the site of 
chemokine production by in situ RT-PCR and 
immunohistochemistry. Other reports localized 
MCP-1 to monocytes/macrophages [5-7,20] and to 
cells within the epidermis [7,20] and dermis [5,20]. 
Likewise, MIP-1 has also been identified in 
macrophages [6,9] as well as within the epidermis 
[16,17]. While we clearly found both MCP-1 and 
MIP-1 message and protein within the epidermis and 
at lower dermal locations, we also consistently observed 
both chemokines associated with hair follicles and 
sebaceous glands. It is interesting that the strongest 
expression was in cells of epithelial lineage. The 
implication of this finding with respect to function 
warrants further study. 
Although the exact role of chemokines in the 
sequence of events and cellular interactions in the 
inflammatory phase of wound healing is still under 
investigation, it has been established that they are key 
molecules in the development of the repair process. 
By examining the differential expression of several 
chemokines/ cytokines, our study suggested that to 
determine adequately the function of any particular 
cytokine in wound healing, its expression must be 
examined, not only with respect to time and place, 
but also in the context of the local milieu of other 
cytokines. Such information may provide new 
strategies for enhancing repair processes by 
manipulating, directly or indirectly, macrophage 
activities at a wound site. 
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